Stocks and Investing Stocks and Investing
Fri, February 9, 2018
Thu, February 8, 2018

Geoffrey Porges Maintained (TBPH) at Buy with Increased Target to $48 on, Feb 8th, 2018


Published on 2024-10-26 02:47:16 - WOPRAI, Geoffrey Porges
  Print publication without navigation


Geoffrey Porges of Leerink Swann, Maintained "Theravance Biopharma, Inc." (TBPH) at Buy with Increased Target from $45 to $48 on, Feb 8th, 2018.

Geoffrey, nor any peers, have made any analyst calls on TBPH in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources